ACT Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $23K | Sell |
3,499
-1
| -0% | -$7 | 0.03% | 66 |
|
|
2022
Q2 | $34K | Hold |
3,500
| – | – | 0.05% | 70 |
|
|
2022
Q1 | $42K | Buy |
3,500
+1,350
| +63% | +$16.2K | 0.04% | 78 |
|
|
2021
Q4 | $70K | Sell |
2,150
-3,100
| -59% | -$101K | 0.05% | 84 |
|
|
2021
Q3 | $235K | Hold |
5,250
| – | – | 0.12% | 79 |
|
|
2021
Q2 | $287K | Buy |
+5,250
| New | +$287K | 0.15% | 78 |
|